All Pharma News
price-trendAsk Us
MSK`s Park: Precision Targeting TF In Pancreatic Cancer At ASCO

MSK`s Park: Precision Targeting TF In Pancreatic Cancer At ASCO
PR NEWSWIRE
12 Jun 2024
Share Share
AI model from NIH, MSKCC predicts immunotherapy responses: study

AI model from NIH, MSKCC predicts immunotherapy responses: study
Conor Hale FIERCE BIOTECH
04 Jun 2024
Share Share
New Study Led by MSKCC Shows Effect of Idylla GeneFusion Assay

New Study Led by MSKCC Shows Effect of Idylla GeneFusion Assay
GLOBENEWSWIRE
04 May 2022
Share Share
Fatal Adverse Event Halts Enrollment in Atara Mesothelioma Trial

Fatal Adverse Event Halts Enrollment in Atara Mesothelioma Trial
Hannah Chudleigh BIOSPACE
19 Feb 2022
Share Share
Biosight Initiates Phase 2 Clinical Trial of Aspacytarabine for MDS and AML

Biosight Initiates Phase 2 Clinical Trial of Aspacytarabine for MDS and AML
GLOBENEWSWIRE
12 Nov 2021
Share Share
Prevencio Demonstrates AI-driven HART CVE Blood Test Radiation Treatment

Prevencio Demonstrates AI-driven HART CVE Blood Test Radiation Treatment
BIOSPACE
27 Oct 2021
Share Share
Bluebird faces lawsuit from Errant Gene on patent fraud

Bluebird faces lawsuit from Errant Gene on patent fraud
J. Sullivan ENDPTS
26 Oct 2021
Share Share
FDA recognizes Memorial Sloan Kettering tumor variant database

FDA recognizes Memorial Sloan Kettering tumor variant database
Kari Oakes RAPS
07 Oct 2021
Share Share
Memorial Sloan Kettering Opens Center In India Amid Rising Demand

Memorial Sloan Kettering Opens Center In India Amid Rising Demand
Russell Flannery FORBES
05 Aug 2021
Share Share